MicroRNA‑204 may participate in the pathogenesis of hypoxic‑ischemic encephalopathy through targeting KLLN

作者: Ronglin Chen , Meixia Wang , Shaopin Fu , Feng Cao , Pengkai Duan

DOI: 10.3892/ETM.2019.7936

关键词:

摘要: Hypoxic-ischemic encephalopathy (HIE) is a common neonatal disease that can lead to high mortality rates. Previous studies have indicated microRNAs (miRs) may be involved in the pathogenesis of HIE; however, specific mechanisms underlying their involvement require further investigation. The aim present study was investigate roles miR-204 and its target gene killin p53 regulated DNA replication inhibitor (KLLN) HIE using rat models. Brain injury induced by surgery incubation hypoxic incubator brain 10-day-old pup rats. On day 3, rats were sacrificed, infarct size determined tetrazolium chloride assay. Terminal deoxynucleotidyl transferase UTP nick-end labeling staining performed detect cell death rate tissue. Following this, tissues collected, reverse transcription-quantitative polymerase chain reaction, western blot analysis immunohistochemistry assays examine expression levels KLLN. Furthermore, neurons cultured transfected with inhibitors or mimics, effect on proliferation apoptosis examined MTT flow cytometric assays. Finally, dual-luciferase reporter assay confirm whether KLLN direct miR-204. significantly downregulated increased tissue (P<0.001). In addition, transfection decreased rates neurons; mimics prompted opposite results. also confirmed Taken together, results demonstrated serve important through targeting

参考文章(36)
Bo-Ai Zhang, Tao Peng, Er-Yi Zhao, Quan-Qing Wen, Yan-Jie Jia, Wen-Juan Guan, [Expression of microRNA in neonatal rats with hypoxic-ischemic brain damage] Chinese journal of contemporary pediatrics. ,vol. 12, pp. 373- 376 ,(2010)
Ann-Marie Looney, Brian H Walsh, Gerard Moloney, Sue Grenham, Ailis Fagan, Gerard W O'Keeffe, Gerard Clarke, John F Cryan, Ted G Dinan, Geraldine B Boylan, Deirdre M Murray, None, Downregulation of Umbilical Cord Blood Levels of miR-374a in Neonatal Hypoxic Ischemic Encephalopathy The Journal of Pediatrics. ,vol. 167, pp. 269- 273 ,(2015) , 10.1016/J.JPEDS.2015.04.060
Emily A Nizialek, Jessica L Mester, Vineet K Dhiman, Dominic J Smiraglia, Charis Eng, KLLN epigenotype–phenotype associations in Cowden syndrome European Journal of Human Genetics. ,vol. 23, pp. 1538- 1543 ,(2015) , 10.1038/EJHG.2015.8
Yu Wang, Deepa Radhakrishnan, Xin He, Donna M. Peehl, Charis Eng, Transcription Factor KLLN Inhibits Tumor Growth by AR Suppression, Induces Apoptosis by TP53/TP73 Stimulation in Prostate Carcinomas, and Correlates With Cellular Differentiation The Journal of Clinical Endocrinology and Metabolism. ,vol. 98, ,(2013) , 10.1210/JC.2012-3490
Y.-j. Cho, P. Liang, Killin is a p53-regulated nuclear inhibitor of DNA synthesis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 105, pp. 5396- 5401 ,(2008) , 10.1073/PNAS.0705410105
Bing Wang, Jillian S Armstrong, Jeong-Hoo Lee, Utpal Bhalala, Ewa Kulikowicz, Hui Zhang, Michael Reyes, Nicole Moy, Dawn Spicer, Junchao Zhu, Zeng-Jin Yang, Raymond C Koehler, Lee J Martin, Jennifer K Lee, Rewarming from Therapeutic Hypothermia Induces Cortical Neuron Apoptosis in a Swine Model of Neonatal Hypoxic–Ischemic Encephalopathy: Journal of Cerebral Blood Flow and Metabolism. ,vol. 35, pp. 781- 793 ,(2015) , 10.1038/JCBFM.2014.245
Pablo J. Gonzalez-Rodriguez, Yong Li, Fabian Martinez, Lubo Zhang, Dexamethasone protects neonatal hypoxic-ischemic brain injury via L-PGDS-dependent PGD2-DP1-pERK signaling pathway. PLOS ONE. ,vol. 9, ,(2014) , 10.1371/JOURNAL.PONE.0114470
Xin Ding, Bin Sun, Jian Huang, Lixiao Xu, Jian Pan, Chen Fang, Yanfang Tao, Shukun Hu, Ronghu Li, Xing Han, Po Miao, Ying Wang, Jian Yu, Xing Feng, The role of miR-182 in regulating pineal CLOCK expression after hypoxia-ischemia brain injury in neonatal rats Neuroscience Letters. ,vol. 591, pp. 75- 80 ,(2015) , 10.1016/J.NEULET.2015.02.026
Yu Wang, Qi Yu, Xin He, Todd Romigh, Jessica Altemus, Charis Eng, Activation of AR sensitizes breast carcinomas to NVP-BEZ235's therapeutic effect mediated by PTEN and KLLN upregulation. Molecular Cancer Therapeutics. ,vol. 13, pp. 517- 527 ,(2014) , 10.1158/1535-7163.MCT-13-0655